News

Dr. Laurie H. Glimcher, dean of Weill Cornell, speaks with four students of the Class of 2016, who just a few weeks ago embarked on the beginning of their medical school journey.

Weill Cornell Medical College's ophthalmology services for diabetic patients received a boost last month, courtesy of a grant from the New York City Council secured by Councilwoman Jessica Lappin.

On Wednesday, Sept. 12, Dr. Peter Bach, professor of public health at Weill Cornell Medical College and the 11th annual Lorraine and Ralph Lubin Distinguished Visiting Professor, presented the keynote lecture, "Intrinsically Incompatible: Comparative Effectiveness Research and Cost Containment," during the David Rogers Health Policy Colloquium at the Weill Greenberg Center.

Blood pressure medications are currently failing millions of Americans, who continue to battle hypertension and remain at increased risk for heart attack and stroke.

The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research.

Dr. Lewis Cantley, a leading cancer researcher, credited with discovering a family of enzymes fundamental to understanding cancer, has been named director of the newly established cancer center at Weill Cornell Medical College and NewYork-Presbyterian Hospital.

Weill Cornell Medical College announced today that it will create a child care center for up to 60 children of its faculty, students and staff near its campus on the Upper East Side of Manhattan.

A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal -- such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.

An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant tuberculosis in the laboratory -- a feat few currently approved TB drugs can do, and resistance to those is spreading.

Less than half of community-based substance abuse treatment programs in the United States currently make HIV testing available on-site or through referral. A new study led by researchers at Weill Cornell Medical College shows the cost-effectiveness of integrating on-site rapid HIV testing into drug treatment programs.

Dr. Laurie Glimcher speaks with internist Dr. Carla Boutin-Foster, recently appointed assistant dean for faculty diversity, who will lead our initiative to enhance the multicultural and multiethnic presence at Weill Cornell.

Awards, honors, prizes and achievements for the week of Aug. 31 - Sept. 7.

A monthly highlight of grants obtained by Weill Cornell Medical College researchers, clinicians and students.

Weill Cornell Medical College has appointed Dr. Carla Boutin-Foster and Dr. Rache M. Simmons to the newly-created leadership positions of assistant deans for faculty diversity in the Office of Faculty Diversity in Medicine and Science.

Weill Cornell Medical College-Qatar students honor faculty plus additional awards, honors, prizes and achievements for the week of Aug. 24 - Aug. 31.

Weill Cornell Medical College has been awarded three new research grants from the Leukemia & Lymphoma Society totaling $1.8 million. The funds will support critically-needed translational research for blood cancers, accelerating promising discoveries from the laboratory to the patient's bedside.

The annual White Coat Ceremony Tuesday was a moment each of the 103 students who comprise the Weill Cornell Medical College Class of 2016 have anxiously anticipated since they first set their sights on a career in medicine.

For a group of researchers from Weill Cornell Medical College and NewYork-Presbyterian Hospital, there's nothing more ethical than formalizing credentialing standards for ethicists who advise patients, families and clinicians on difficult cases. For that reason, these researchers have devised and implemented a process at NewYork-Presbyterian Hospital they hope will forge a national paradigm for credentialing clinical ethics consultants who often counsel on issues of life and death.

Dr. Louis Aronne advocates for obesity drug outcome measures plus additional awards, honors, prizes and achievements for the week of Aug. 17 - Aug. 24.